EUROFINS SCIENTIFIC SE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.19 EUR | +2.59% |
|
-11.40% | -19.91% |
| 25/06 | Market Update-Europe closes lower in a session marked by a wait-and-see attitude | RE |
| 25/06 | EUROFINS : Oddo BHF confirms its recommendation on the stock | CF |
This Alphavalue article, the European leader in independent research, is only available to subscribers .Alphavalue is exclusively on MarketScreener. To unlock the article, SUBSCRIBE!
Already a customer? Log In
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Calendar
24/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
46
EUR
Average target price
60.88
EUR
Spread / Average Target
+32.34%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.91% | 9.5B | |
| +24.83% | 89.17B | |
| -24.15% | 75.87B | |
| +2.32% | 27.41B | |
| -10.57% | 17.52B | |
| +0.04% | 17.04B | |
| -0.10% | 15.36B | |
| +79.20% | 13.67B | |
| +78.64% | 13.18B | |
| -25.61% | 12.83B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific: Q1 sees a lacklustre start to the year; 2024 outlook confirmed
